Compare Bio Protocol (BIO) vs Ripple (XRP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs Ripple — how do they compare? Bio Protocol trades at Rp514.67 (market cap Rp1,15T, Rp256,3M 24h volume), while Ripple trades at Rp19,386 (market cap Rp1.207,63T, Rp17,99T 24h volume). The key difference: Ripple is far larger — about 1050.1× Bio Protocol's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 62,5B / 100B XRP (63%) for Ripple. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Ripple for 68 Days on average.
| BIO | XRP | |
|---|---|---|
Market Cap | Rp1,15T | Rp1.207,63T |
Volume (24h) | Rp256,3M | Rp17,99T |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 62,5B / 100B XRP (63%) |
Typical Hold Time | 16 Days | 68 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XRP is trading at Rp19,329 with a market cap of Rp1,207.63T, showing a bearish technical trend as it approaches its fifth consecutive monthly decline. The token faces selling pressure but finds support near Rp19,032, with oversold RSI_6 at 15.60 suggesting potential for a short-term bounce. Recent ecosystem developments include Deutsche Bank integrating Ripple's payment rails and Société Générale deploying its euro stablecoin on XRP Ledger, indicating growing institutional adoption despite price weakness.
Overall outlook remains cautious with near-term downside risks from bearish momentum, but long-term opportunities exist from expanding blockchain utility and potential regulatory tailwinds like Japan's tax reforms. Key risks include high volatility, regulatory uncertainty, and liquidity constraints amid prolonged selling pressure.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About Ripple
A crypto asset was created by Ripple to be a speedy, less costly and more scalable alternative to both other digital assets and existing monetary payment platforms like SWIFT. It is the native digital asset on the XRP Ledger—an open-source, permissionless and decentralized blockchain technology that can settle transactions in 3-5 seconds.
Read more on XRP →
